Table 1.

Characteristics of study participants in the vaccine-priority group and non-priority group.

Characteristics	Total n (%)	Vaccine Priority group n (%)	Non-priority group n (%)	P value
Total	8742 (100)	3902 (44.6)	4840 (55.4)
Gender
Male	3207 (36.7)	1529 (39.2)	1678 (34.7)	<0.001
Female	5535 (63.3)	2373 (60.8)	3162 (65.3)
Age group, years
<30	2632 (30.1)	993 (25.4)	1639 (33.9)	<0.001
30–39	3277 (37.5)	1402 (35.9)	1875 (38.7)
40–49	1677 (19.2)	924 (23.7)	753 (15.6)
≥50	1156 (13.2)	583 (14.9)	573 (11.8)
Education
≤High school	1275 (14.6)	463 (11.9)	812 (16.8)	<0.001
Bachelor’s degree	5547 (63.5)	2643 (67.7)	2904 (60.0)
≥Master’s degree	1920 (22.0)	796 (20.4)	1124 (23.2)
Residence
Urban	6895 (78.9)	2966 (76.0)	3929 (81.2)	<0.001
Rural	1847 (21.1)	936 (24.0)	911 (18.8)